-
公开(公告)号:WO2011149950A3
公开(公告)日:2012-04-12
申请号:PCT/US2011037758
申请日:2011-05-24
申请人: UNIV ROCHESTER , GELBARD HARRIS A , DEWHURST STEPHEN , GOODFELLOW VAL S , WIEMANN TORSTEN , RAVULA SATHEESH BABU , LOWETH COLIN J
发明人: GELBARD HARRIS A , DEWHURST STEPHEN , GOODFELLOW VAL S , WIEMANN TORSTEN , RAVULA SATHEESH BABU , LOWETH COLIN J
IPC分类号: C07D471/04 , A61K31/437 , A61K31/4985 , A61P3/00 , C07D487/04
CPC分类号: A61K31/437 , A61K31/444 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D471/04 , C07D487/04 , C07D519/00
摘要: Provided are compounds having an inhibitory effect on kinases including Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders that comprise the inhibition of Mixed Lineage Kinases.
摘要翻译: 提供对对包括混合谱系激酶在内的激酶具有抑制作用的化合物。 还提供了药物组合物,制备化合物的方法,合成中间体以及独立地或与其它治疗剂组合使用该化合物的方法,用于治疗受混合谱系激酶抑制影响的疾病和病症。 还提供了治疗包含抑制混合谱系激酶的神经精神障碍的方法。
-
公开(公告)号:WO2010068483A2
公开(公告)日:2010-06-17
申请号:PCT/US2009/065878
申请日:2009-11-25
申请人: UNIVERSITY OF ROCHESTER , GELBARD, Harris, A. , DEWHURST, Stephen , GOODFELLOW, Val, S. , WIEMANN, Torsten
IPC分类号: C07D487/14 , C07D487/04 , A61P25/00 , A61K31/437
CPC分类号: A61K31/437 , A61K31/438 , A61K31/444 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K31/553 , A61K45/06 , C07D471/04 , C07D471/10 , C07D487/04 , A61K2300/00
摘要: Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases.
摘要翻译: 只要是对混合谱系激酶具有抑制作用的化合物即可。 还提供了药物组合物,制备所述化合物的方法,合成中间体以及使用所述化合物的方法,独立地或与其他治疗剂组合用于治疗受混合谱系激酶抑制影响的疾病和病症。 还提供了治疗包含混合谱系激酶抑制的神经精神障碍的方法。 p>
-
3.
公开(公告)号:WO9849190A2
公开(公告)日:1998-11-05
申请号:PCT/US9808259
申请日:1998-04-24
申请人: CORTECH INC , SPRUCE LYLE W , GYORKOS ALBERT C , CHERONIS JOHN C , GOODFELLOW VAL S , LEIMER AXEL H , YOUNG JOHN M , GERRITY JAMES IVAN
发明人: SPRUCE LYLE W , GYORKOS ALBERT C , CHERONIS JOHN C , GOODFELLOW VAL S , LEIMER AXEL H , YOUNG JOHN M , GERRITY JAMES IVAN
CPC分类号: C07K5/06078 , A61K38/00 , C07K5/06043 , C07K5/06052 , C07K5/0812 , C07K5/0819
摘要: The present invention relates to cystein protease inhibitors of general formula (I), wherein Z is a cysteine protease binding moiety; X and Y are S, O or optionally substituted N; and R1 is optionally substituted alkyl or aryl.
摘要翻译: 本发明涉及通式(I)的半胱氨酸蛋白酶抑制剂,其中Z是半胱氨酸蛋白酶结合部分; X和Y是S,O或任选取代的N; 并且R 1是任选取代的烷基或芳基。
-
公开(公告)号:WO2010065461A1
公开(公告)日:2010-06-10
申请号:PCT/US2009/066116
申请日:2009-11-30
申请人: ACCUTHERA, INC. , CHERONIS, John, C. , GOODFELLOW, Val, S. , LOWETH, Colin, J. , RAEISSI, Shamsi
IPC分类号: A61K38/00
CPC分类号: C07K5/06052 , A61K38/00 , C07K5/021
摘要: The present invention provides compounds of formula (I): where X is R 1 -(CR 3 R 4 ) n OC(O)-; R 1 -(CR 3 R 4 ) n C(O)-; R 1 -C(O)NH(CR 3 R 4 ) n OC(O)-; R 1 -C(O)NH(CR 3 R 4 ) n C(O)-; R 1 -C(O)(CR 3 R 4 ) n OC(O)-; or R 1 -C(O)(CR 3 R 4 ) n C(O)-; where R 1 is optionally substituted C 5-10 aryl or heteroaryl; OH or NH 2; where R 3 and R 4 are independently H or methyl; and Y is CF to 6; and formula (II) where R 2 is C 1-8 alkyl optionally substituted with halo or-OH; -(CR 6 R 7 )P-C 5-6 aryl optionally substituted with halo, -OH, C1-8 alkyl, C1-8 haloalkyl, -(CH2)mC(O)NH2 or -(CH 2 ) m OCH 3 ; where R 6 and R 7 are independently H or methyl; m is O to 4, and p is O or 1 or a pharmaceutically acceptable salt, ester, metabolite or prodrug thereof.
摘要翻译: 本发明提供式(I)化合物:其中X为R1-(CR3R4)nOC(O) - ; R1-(CR3R4)NC(O) - ; R1-C(O)NH(CR 3 R 4)NOC(O) - ; R1-C(O)NH(CR 3 R 4)NC(O) - ; R1-C(O)(CR 3 R 4)NOC(O) - ; 或R 1 -C(O)(CR 3 R 4)n C(O) - ; 其中R 1是任选取代的C 5-10芳基或杂芳基; OH或NH2; 其中R3和R4独立地是H或甲基; Y为CF〜6; 和式(II)其中R2是任选被卤素或-OH取代的C 1-8烷基; -OH,C 1-8烷基,C 1-8卤代烷基, - (CH 2)m C(O)NH 2或 - (CH 2)m OCH 3), - (CR 6 R 7)任选被卤素取代的C 1 -C 6 - 其中R 6和R 7独立地为H或甲基; m为0至4,p为O或1或其药学上可接受的盐,酯,代谢物或前药。
-
公开(公告)号:WO2011149950A2
公开(公告)日:2011-12-01
申请号:PCT/US2011/037758
申请日:2011-05-24
申请人: UNIVERSITY OF ROCHESTER , GELBARD, Harris, A. , DEWHURST, Stephen , GOODFELLOW, Val, S. , WIEMANN, Torsten , RAVULA, Satheesh, Babu , LOWETH, Colin, J.
发明人: GELBARD, Harris, A. , DEWHURST, Stephen , GOODFELLOW, Val, S. , WIEMANN, Torsten , RAVULA, Satheesh, Babu , LOWETH, Colin, J.
IPC分类号: C07D471/04 , C07D487/04 , A61K31/437 , A61K31/4985 , A61P3/00
CPC分类号: A61K31/437 , A61K31/444 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D471/04 , C07D487/04 , C07D519/00
摘要: Provided are compounds having an inhibitory effect on kinases including Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders that comprise the inhibition of Mixed Lineage Kinases.
摘要翻译: 提供对对包括混合谱系激酶在内的激酶具有抑制作用的化合物。 还提供了药物组合物,制备化合物的方法,合成中间体以及独立地或与其它治疗剂组合使用该化合物的方法,用于治疗受混合谱系激酶抑制影响的疾病和病症。 还提供了治疗包含抑制混合谱系激酶的神经精神障碍的方法。
-
公开(公告)号:WO2010068483A3
公开(公告)日:2010-09-30
申请号:PCT/US2009065878
申请日:2009-11-25
IPC分类号: C07D487/14 , A61K31/437 , A61P25/00 , C07D487/04
CPC分类号: A61K31/437 , A61K31/438 , A61K31/444 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K31/553 , A61K45/06 , C07D471/04 , C07D471/10 , C07D487/04 , A61K2300/00
摘要: Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases.
摘要翻译: 提供对混合谱系激酶具有抑制作用的化合物。 还提供了药物组合物,制备化合物的方法,合成中间体,以及独立地或与其它治疗剂组合使用化合物用于治疗受血液谱系激酶抑制影响的疾病和病症的方法。 还提供了治疗包含抑制混合谱系激酶的神经精神障碍的方法。
-
7.
公开(公告)号:WO9849190A9
公开(公告)日:1999-04-15
申请号:PCT/US9808259
申请日:1998-04-24
申请人: CORTECH INC , SPRUCE LYLE W , GYORKOS ALBERT C , CHERONIS JOHN C , GOODFELLOW VAL S , LEIMER AXEL H , YOUNG JOHN M , GERRITY JAMES IVAN
发明人: SPRUCE LYLE W , GYORKOS ALBERT C , CHERONIS JOHN C , GOODFELLOW VAL S , LEIMER AXEL H , YOUNG JOHN M , GERRITY JAMES IVAN
IPC分类号: A61K38/00 , C07K5/06 , C07K5/062 , C07K5/087 , C07K5/093 , A61K31/41 , A61K38/05 , A61K38/06 , A61K38/07 , C07D271/06 , C07D271/10 , C07D413/12 , C07D413/14 , C07D417/12 , C07K5/08 , C07K5/10 , G01N33/52
CPC分类号: C07K5/06078 , A61K38/00 , C07K5/06043 , C07K5/06052 , C07K5/0812 , C07K5/0819
摘要: The present invention relates to cystein protease inhibitors of general formula (I), wherein Z is a cysteine protease binding moiety; X and Y are S, O or optionally substituted N; and R1 is optionally substituted alkyl or aryl.
摘要翻译: 本发明涉及通式(I)的半胱氨酸蛋白酶抑制剂,其中Z是半胱氨酸蛋白酶结合部分; X和Y是S,O或任选取代的N; 并且R 1是任选取代的烷基或芳基。
-
-
-
-
-
-